Compounds > oxybutynin

oxybutynin and risedronic acid

oxybutynin has been researched along with risedronic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Andreetta, HA; Cortizo, MS; Pasqualone, M1
Cui, P; Jia, B; Kong, F; Wang, D1
Ali, A; Aqil, M; Jabi, B; Mujeeb, M; Sultana, N; Sultana, Y; Waheed, A; Yaqub Khan, M1

Reviews

1 review(s) available for oxybutynin and risedronic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for oxybutynin and risedronic acid

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Risedronate transdermal delivery system based on a fumaric copolymer for therapy of osteoporosis.
    Materials science & engineering. C, Materials for biological applications, 2017, Jul-01, Volume: 76

    Topics: Administration, Cutaneous; Calorimetry, Differential Scanning; Drug Delivery Systems; Humans; Osteoporosis; Reproducibility of Results; Risedronic Acid; Transdermal Patch

2017
Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis.
    Acta biochimica Polonica, 2019, Dec-17, Volume: 66, Issue:4

    Topics: Alendronate; Animals; Bone Density Conservation Agents; Calcium; Drug Delivery Systems; Drug Therapy, Combination; Female; Osteoporosis; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Risedronic Acid; Transdermal Patch

2019
Dissolving microneedle transdermal patch loaded with Risedronate sodium and Ursolic acid bipartite nanotransfersomes to combat osteoporosis: Optimization, characterization, in vitro and ex vivo assessment.
    International journal of pharmaceutics, 2023, Sep-25, Volume: 644

    Topics: Drug Delivery Systems; Humans; Osteoporosis; Risedronic Acid; Transdermal Patch; Ursolic Acid

2023